Clinical Trial 55268

Berlin, NJ 08009


Summary:

ADVANCE-2: Addressing Dementia Via Agitation-Centered Evaluation: A Randomized, Double-blind, Placebo-controlled Trial to Assess the Efficacy and Safety of AXS-05 for the Treatment of Alzheimer’s Disease Agitation



Criteria:
  • 65–90 years old
  • Be diagnosed with Alzheimer's disease
  • Exhibit behaviors associated with agitation
  • Have a caregiver/informant present
  • Additional criteria apply


Qualified Participants May Receive:

Up to $650 for time and travel-related expenses


Clinical trials are medical research studies designed to test the safety and/or effectiveness of new investigational drugs, devices, or treatments in humans. These studies are conducted worldwide for a range of conditions and illnesses. Learn more about clinical research and participating in a study at About Clinical Trials.